What Plasmapp does

Plasmapp Co., Ltd. is a South Korean bio-plasma deep-tech medical device company that develops low-temperature plasma technology for healthcare applications. Founded in 2014 and publicly listed on KOSDAQ under ticker 405000, the company has assembled a portfolio of 158 patent cases and obtained regulatory certifications from over 26 countries. Its technology platform addresses three application domains: biological inactivation (sterilization), regenerative activation (implants), and stimulative therapy (skin treatment). Plasmapp is headquartered in Seongnam-si, South Korea, and operates with 51-100 employees.

The company's commercial portfolio is organized around two principal brands. STERLINK is a modular family of low-temperature plasma sterilizers comprising premium models (FPS-15s Plus, mini, lab) and universal models (U420/lite, U510/lite+, Lite+) for hospitals, clinics, and laboratories. ACTILINK is a plasma regenerative activator for dental and medical implants. Revenue is generated primarily through hardware sales of these devices to medical institutions, with ophthalmology hospitals and clinics treated as the prioritized primary vertical. Distribution combines direct enterprise sales with a channel-partner network covering approximately 50 countries across the Americas, EMEA, and Asia Pacific. The most material commercial event in the company's recent history is a two-year exclusive supply agreement with DS Medical for 150 STERLINK Lite+ units, alongside entry into the U.S. ophthalmic healthcare market in late 2025.

Plasmapp's business model is hardware-centric and the company has historically been unprofitable, but management has executed significant operational restructuring—including outsourcing improvements, cost streamlining, and headcount adjustments—to reduce annual operating losses by more than 10 billion KRW and officially resolve its capital impairment status by early 2026. A 5 billion KRW capital increase from corporate investors Dreamtech and L&C Bio in December 2023 funded new device development, production transfer, and growth with minimal capex. Leadership is anchored by founder and CEO Youbong Lim, with Sun Gyu Kim serving as Chief Marketing Officer.

Name

Plasmapp

Legal name

Plasmapp Co., Ltd.

Website

https://plasmapp.co.kr

Company type

Public

Founded year

2014

Operating status

Operating

Headcount range

51–100 employees

Short description

Plasmapp Co., Ltd. is a South Korean KOSDAQ-listed (405000) bio-plasma deep-tech medical device company that develops low-temperature plasma sterilization (STERLINK) and regenerative activation (ACTILINK) systems for hospitals, ophthalmology clinics, and implant providers across approximately 50 countries.

Ownership category

akta.pro rank

Product category

Medical Device Sterilization Equipment

NAICS

Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Home Infusion Therapy Providers (HLAFAEAE)

akta.pro secondary industry

Plasma-Derived Therapeutics (immunoglobulins, albumin, clotting factors) (HLAAAAAI)

Keywords

• Low temperature plasma sterilization
• Medical device sterilization
• Plasma regenerative activation
• Ophthalmic sterilization equipment
• Medical plasma technology

Headquarters

HQ city

Daejeon

HQ country

South Korea

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales (STERLINK & ACTILINK): Plasmapp generates revenue primarily through the sale of medical devices including low-temperature plasma sterilizers (STERLINK line) and plasma regenerative activators (ACTILINK). The company manufactures and sells sterilizers to medical institutions including ophthalmology hospitals and clinics.
2. Capital Increase for Growth: Plasmapp raised 5 billion won through capital increase to fund development of new devices, transfer of production, and support increasing sales with minimal CAPEX. The company plans to achieve quarterly breakeven within 2024 through internal restructuring.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Plasmapp develops, manufactures, and sells low-temperature plasma-based medical devices, primarily the STERLINK line of plasma sterilizers (premium and universal models) for hospitals, ophthalmology clinics, and laboratories, and the ACTILINK line of plasma regenerative activators for dental and medical implant procedures. The company also sells related accessories and provides customized sterilization/regeneration solutions to medical institutions in approximately 50 countries.

Product overview

Plasmapp is a bio-plasma deep-tech company offering two core product lines: STERLINK (low-temperature plasma sterilizers) and ACTILINK (plasma regenerative activators for implants). The STERLINK line includes premium models (FPS-15s Plus, mini, lab) and universal models (U420/lite, U510/lite+, Lite+), designed for medical facility sterilization with applications spanning ophthalmology, general surgery, and laboratory settings. The ACTILINK motion/reborn provides regenerative activation technology for medical implants. The company holds 158 patents and certifications from over 26 countries.

Differentiator

Problem solved

Functional benefit

Brands

• STERLINK: Low Temperature Plasma Sterilizer product line including STERLINK FPS-15s Plus, STERLINK mini, STERLINK lab, STERLINK U420/lite, STERLINK U510/lite+
• ACTILINK

Products and services

• STERLINK FPS-15s Plus Premium line low-temperature plasma sterilizer for medical facility sterilization, designed for hospitals and clinics requiring chemical-free, low-temperature sterilization of medical devices.
• STERLINK mini Compact premium line low-temperature plasma sterilizer suitable for smaller medical facilities needing effective plasma sterilization in a reduced footprint.
• STERLINK lab Laboratory-grade low-temperature plasma sterilizer in the premium line, intended for research and clinical laboratory settings requiring plasma-based sterilization.
• STERLINK U420/lite Universal line low-temperature plasma sterilizer offering cost-effective plasma sterilization for a range of medical applications and healthcare providers.
• STERLINK U510/lite+ Universal line low-temperature plasma sterilizer with enhanced features, applicable to ophthalmology and general medical sterilization use cases.
• STERLINK Lite+ Low-temperature plasma sterilizer variant specifically designed for ophthalmology hospitals and clinics, delivered under a two-year exclusive supply contract with DS Medical for the Korean and U.S. ophthalmic markets.
• ACTILINK motion/reborn Plasma regenerative activator for dental and medical implants, leveraging plasma-based biological regeneration and activation technology to improve implant integration and healing outcomes for implantology professionals.

Quantifiable outcome

• Reduced annual operating losses by more than 10 billion won over the past year
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• DS MedicalcoreChannel Partner/ Reseller/ Distributor · 20 March 2026DS Medical entered into a two-year exclusive supply contract with Plasmapp for 150 units of STERLINK Lite+ low-temperature plasma sterilizers to be delivered to ophthalmology hospitals and clinics. This partnership represents Plasmapp's key distribution channel for its ophthalmology-focused sterilization products in the Korean market.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Steris plc: Steris is a global leader in sterilization and infection prevention, offering low-temperature hydrogen peroxide sterilization systems (V-PRO) that directly compete with Plasmapp's STERLINK plasma sterilizers in hospital and surgical center settings. Comparable as the dominant incumbent in medical device sterilization.
• Johnson & Johnson (Advanced Sterilization Products): ASP, a J&J subsidiary, markets the Sterrad system, the most widely adopted low-temperature hydrogen peroxide plasma sterilizer globally. Directly comparable as a competing low-temperature sterilization modality targeted at the same ophthalmology, surgical, and hospital customers.
• Getinge: Getinge is a major medical technology company offering steam and low-temperature sterilization solutions, including the Stericool hydrogen peroxide system. Comparable as a broad sterilization incumbent competing for the same hospital sterilization budgets as STERLINK.
• Solventum (formerly 3M Health Care): Solventum provides sterilization monitoring and infection prevention products, and previously distributed the Attest hydrogen peroxide sterilization system through 3M. Comparable as a broad incumbent serving healthcare sterilization workflows with overlapping customer relationships.

Direct peers

• Tuttnauer: Tuttnauer manufactures autoclaves and low-temperature sterilizers for hospitals, dental clinics, and laboratories, with a comparable mid-sized, multi-product sterilization portfolio. Directly competes with Plasmapp's STERLINK line across ambulatory surgery centers and ophthalmology/dental clinics.
• Matachana: Matachana is a European specialist in low-temperature sterilization using hydrogen peroxide and other chemistries, serving hospitals and research labs. Comparable as a focused low-temperature sterilization competitor targeting similar hospital and clinical customers as Plasmapp.
• Steelco Group: Steelco is an Italian manufacturer of sterilization, disinfection, and laboratory equipment for hospitals and pharmaceutical cleanrooms. Comparable as a direct mid-market sterilization equipment competitor with overlapping product categories to STERLINK.
• Cisa Group (Getinge affiliate): Cisa Group produces low-temperature sterilizers using hydrogen peroxide and peracetic acid for healthcare facilities, with comparable product positioning to STERLINK in hospital infection prevention.

Regional players

• Shinva Medical Instrument: Shinva is one of China's largest sterilization and medical equipment manufacturers, supplying autoclaves and plasma sterilizers primarily across Asia. Comparable as a regional low-temperature sterilization peer serving similar hospital and clinical customers, though predominantly in the Chinese market.

Others

• Renolit SE: Renolit supplies specialty films and surface treatment technologies used in medical device packaging and sterilization workflows. Relevant as an adjacent supplier/comparator in the broader medical plasma and surface treatment value chain overlapping with Plasmapp's plasma applications.

Market position

Strengths1 record

Weaknesses4 records

Competitive moat3 records

Customer concentration

• YouTubeyoutube.com/plasmapp2015
• LinkedInlinkedin.com/company/plasmapp-global

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds6 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Plasmapp